Your browser doesn't support javascript.
Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19.
Jones, Nick K; Rivett, Lucy; Sparkes, Dominic; Forrest, Sally; Sridhar, Sushmita; Young, Jamie; Pereira-Dias, Joana; Cormie, Claire; Gill, Harmeet; Reynolds, Nicola; Wantoch, Michelle; Routledge, Matthew; Warne, Ben; Levy, Jack; Córdova Jiménez, William David; Samad, Fathima Nisha Begum; McNicholas, Chris; Ferris, Mark; Gray, Jane; Gill, Michael; Curran, Martin D; Fuller, Stewart; Chaudhry, Afzal; Shaw, Ashley; Bradley, John R; Hannon, Gregory J; Goodfellow, Ian G; Dougan, Gordon; Smith, Kenneth Gc; Lehner, Paul J; Wright, Giles; Matheson, Nicholas J; Baker, Stephen; Weekes, Michael P.
  • Jones NK; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Rivett L; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Sparkes D; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Forrest S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Sridhar S; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Young J; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Pereira-Dias J; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Cormie C; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Gill H; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Reynolds N; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Wantoch M; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Routledge M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Warne B; Wellcome Sanger Institute, Hinxton, United Kingdom.
  • Levy J; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Córdova Jiménez WD; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Samad FNB; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • McNicholas C; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Ferris M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Gray J; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Gill M; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Curran MD; Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.
  • Fuller S; Department of Haematology, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Chaudhry A; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Shaw A; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom.
  • Bradley JR; Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, United Kingdom.
  • Hannon GJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, United Kingdom.
  • Goodfellow IG; Institute for Manufacturing, Department of Engineering, University of Cambridge, Cambridge, United Kingdom.
  • Dougan G; Institute for Manufacturing, Department of Engineering, University of Cambridge, Cambridge, United Kingdom.
  • Smith KG; Institute for Manufacturing, Department of Engineering, University of Cambridge, Cambridge, United Kingdom.
  • Lehner PJ; Improvement and Transformation Team, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Wright G; Occupational Health and Wellbeing, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Matheson NJ; Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Baker S; Cancer Research United Kingdom Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Elife ; 92020 06 19.
Article in English | MEDLINE | ID: covidwho-607959
ABSTRACT
Previously, we showed that 3% (31/1032)of asymptomatic healthcare workers (HCWs) from a large teaching hospital in Cambridge, UK, tested positive for SARS-CoV-2 in April 2020. About 15% (26/169) HCWs with symptoms of coronavirus disease 2019 (COVID-19) also tested positive for SARS-CoV-2 (Rivett et al., 2020). Here, we show that the proportion of both asymptomatic and symptomatic HCWs testing positive for SARS-CoV-2 rapidly declined to near-zero between 25th April and 24th May 2020, corresponding to a decline in patient admissions with COVID-19 during the ongoing UK 'lockdown'. These data demonstrate how infection prevention and control measures including staff testing may help prevent hospitals from becoming independent 'hubs' of SARS-CoV-2 transmission, and illustrate how, with appropriate precautions, organizations in other sectors may be able to resume on-site work safely.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Mass Screening / Health Personnel / Coronavirus Infections / Clinical Laboratory Techniques / Pandemics / Occupational Diseases Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Country/Region as subject: Europa Language: English Year: 2020 Document Type: Article Affiliation country: ELife.59391

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Mass Screening / Health Personnel / Coronavirus Infections / Clinical Laboratory Techniques / Pandemics / Occupational Diseases Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Country/Region as subject: Europa Language: English Year: 2020 Document Type: Article Affiliation country: ELife.59391